An imbalance between the pro-inflammatory CD4+IL17+ T-cells and the anti-inflammatory CD4+FOXP3+ regulatory T-cells (Tregs) in the gut may be a key determinant of early AD development (Kim et al., 2020). The gene discussed is CD4; the disease is Alzheimer disease.